Profile
Full Name
NeuroPace, Inc.Ticker Symbol
NPCEExchange
NASDAQSector
HealthcareIndustry
Medical DevicesCountry
United StatesIPO
April 22, 2021Indexes
Not includedWebsite
http://www.neuropace.comEmployees
184Key Details
Price
$10.42(-2.07%)
Market cap
$339.28M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$79.91M(+22.14% YoY)
Annual EPS
-$0.93(+26.77% YoY)
PE ratio
-
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
NeuroPace doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 5, 25 Cantor Fitzgerald
OverweightJan 30, 25 Wells Fargo
OverweightJan 21, 25 UBS
BuyDec 17, 24 JP Morgan
OverweightNov 13, 24 Wells Fargo
OverweightAug 14, 24 Wells Fargo
OverweightAug 14, 24 Cantor Fitzgerald
OverweightJul 15, 24 Morgan Stanley
Equal-WeightMay 9, 24 Cantor Fitzgerald
OverweightMar 14, 24 Wells Fargo
OverweightInstitutional Ownership
- What is the ticker symbol for NeuroPace?
- Does NeuroPace pay dividends?
- What sector is NeuroPace in?
- What industry is NeuroPace in?
- What country is NeuroPace based in?
- When did NeuroPace go public?
- Is NeuroPace in the S&P 500?
- Is NeuroPace in the NASDAQ 100?
- Is NeuroPace in the Dow Jones?
- When was NeuroPace's last earnings report?
- When does NeuroPace report earnings?
- Should I buy NeuroPace stock now?
What is the ticker symbol for NeuroPace?
The ticker symbol for NeuroPace is NASDAQ:NPCE
Does NeuroPace pay dividends?
No, NeuroPace does not pay dividends
What sector is NeuroPace in?
NeuroPace is in the Healthcare sector
What industry is NeuroPace in?
NeuroPace is in the Medical Devices industry
What country is NeuroPace based in?
NeuroPace is headquartered in United States
When did NeuroPace go public?
NeuroPace's initial public offering (IPO) was on April 22, 2021
Is NeuroPace in the S&P 500?
No, NeuroPace is not included in the S&P 500 index
Is NeuroPace in the NASDAQ 100?
No, NeuroPace is not included in the NASDAQ 100 index
Is NeuroPace in the Dow Jones?
No, NeuroPace is not included in the Dow Jones index
When was NeuroPace's last earnings report?
NeuroPace's most recent earnings report was on Mar 4, 2025
When does NeuroPace report earnings?
The next expected earnings date for NeuroPace is May 8, 2025
Should I buy NeuroPace stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions